CoChat
Sign Up
Cited by 53

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Effects of oxysterols on the blood–brain barrier: Implications for Alzheimer’s disease

Gosselet, Fabien, Saint-Pol, Julien, Fenart, Laurence·2014·Biochemical and Biophysical Research Communications
DOI 10.1016/j.bbrc.2013.11.059
Open this paper in CoChat — free account

Verifying this paper

8 of 9 steps done · this page updates itself — you can leave and come back

  1. Registry recordVerified
  2. Full textFetching the open-access text — a few minutes for a paper we haven’t read before
  3. Reference listNot fetched yet
  4. Reference checkNot run yet for this paper
  5. StatisticsNeeds the full text
  6. ClaimsNeeds the full text
  7. Cited sourcesNeeds claims to check
  8. Self-checkNeeds the full text
  9. VerificationFindings verified

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2013.11.059

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 54

  1. Martins, 2009, Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease, J. Neurochem., 111, 1275, 10.1111/j.1471-4159.2009.06408.x · DOI
  2. Abildayeva, 2006, 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux, J. Biol. Chem., 281, 12799, 10.1074/jbc.M601019200 · DOI · Paper page
  3. Karten, 2006, Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia, J. Biol. Chem., 281, 4049, 10.1074/jbc.M508915200 · DOI · Paper page
  4. Kim, 2007, Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation, J. Biol. Chem., 282, 2851, 10.1074/jbc.M607831200 · DOI · Paper page
  5. Lund, 1999, CDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain, Proc. Natl. Acad. Sci. USA, 96, 7238, 10.1073/pnas.96.13.7238 · DOI · Paper page
  6. Ohyama, 2006, Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes, J. Biol. Chem., 281, 3810, 10.1074/jbc.M505179200 · DOI
  7. Lutjohann, 1996, Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation, Proc. Natl. Acad. Sci. USA, 93, 9799, 10.1073/pnas.93.18.9799 · DOI · Paper page
  8. Heverin, 2005, Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain, J. Lipid Res., 46, 1047, 10.1194/jlr.M500024-JLR200 · DOI
  9. Vaya, 2007, Oxysterols, cholesterol homeostasis, and Alzheimer disease, J. Neurochem., 102, 1727, 10.1111/j.1471-4159.2007.04689.x · DOI
  10. Spady, 1987, Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit, J. Lipid Res., 28, 32, 10.1016/S0022-2275(20)38731-9 · DOI
  11. Wilson, 1970, The measurement of the exchangeable pools of cholesterol in the baboon, J. Clin. Invest., 49, 655, 10.1172/JCI106277 · DOI
  12. Chobanian, 1962, Body cholesterol metabolism in man. II. Measurement of the body cholesterol miscible pool and turnover rate, J. Clin. Invest., 41, 1738, 10.1172/JCI104632 · DOI
  13. Chobanian, 1962, Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol, J. Clin. Invest., 41, 1732, 10.1172/JCI104631 · DOI
  14. Golomb, 2000, Low cholesterol and violent crime, J. Psychiatr. Res., 34, 301, 10.1016/S0022-3956(00)00024-8 · DOI
  15. Virkkunen, 1984, Serum cholesterol in aggressive conduct disorder: a preliminary study, Biol. Psychiatry, 19, 435
  16. Golomb, 1998, Cholesterol and violence: is there a connection?, Ann. Intern. Med., 128, 478, 10.7326/0003-4819-128-6-199803150-00009 · DOI
  17. Fitz, 2012, Abca1 deficiency affects Alzheimer’s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice, J. Neurosci., 32, 13125, 10.1523/JNEUROSCI.1937-12.2012 · DOI · Paper page
  18. George, 2004, APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease, Neurobiol. Dis., 16, 124, 10.1016/j.nbd.2004.01.009 · DOI
  19. Refolo, 2000, Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model, Neurobiol. Dis., 7, 321, 10.1006/nbdi.2000.0304 · DOI · Paper page
  20. Sparks, 1994, Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol, Exp. Neurol., 126, 88, 10.1006/exnr.1994.1044 · DOI · Paper page
  21. Kivipelto, 2001, Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study, BMJ, 322, 1447, 10.1136/bmj.322.7300.1447 · DOI · Paper page
  22. Karasinska, 2009, Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function, J. Neurosci., 29, 3579, 10.1523/JNEUROSCI.4741-08.2009 · DOI · Paper page
  23. Dehouck, 1997, A new function for the LDL receptor: transcytosis of LDL across the blood–brain barrier, J. Cell Biol., 138, 877, 10.1083/jcb.138.4.877 · DOI · Paper page
  24. Gosselet, 2011, The mysterious link between cholesterol and Alzheimer’s Disease: is the blood–brain barrier a suspect?, J. Alzheimer’s Dis. Parkinsonism, 1
  25. Cecchelli, 2007, Modelling of the blood–brain barrier in drug discovery and development, Nat. Rev. Drug Discov., 6, 650, 10.1038/nrd2368 · DOI
  26. Abbott, 2010, Structure and function of the blood–brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030 · DOI · Paper page
  27. Gosselet, 2011, Role of the blood–brain barrier in Alzheimer’s disease, Med. Sci. (Paris), 27, 987, 10.1051/medsci/20112711015 · DOI
  28. Abbott, 2006, Astrocyte-endothelial interactions at the blood–brain barrier, Nat. Rev. Neurosci., 7, 41, 10.1038/nrn1824 · DOI · Paper page
  29. Ohtsuki, 2004, MRNA expression of the ATP-binding cassette transporter subfamily A (ABCA) in rat and human brain capillary endothelial cells, Biol. Pharm. Bull., 27, 1437, 10.1248/bpb.27.1437 · DOI
  30. Akanuma, 2008, Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood–brain barrier, Neurochem. Int., 52, 669, 10.1016/j.neuint.2007.08.012 · DOI · Paper page
  31. Gosselet, 2009, Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood–brain barrier: use of an in vitro model, Brain Res., 1249, 34, 10.1016/j.brainres.2008.10.036 · DOI
  32. Panzenboeck, 2002, ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood–brain barrier constituted of porcine brain capillary endothelial cells, J. Biol. Chem., 277, 42781, 10.1074/jbc.M207601200 · DOI · Paper page
  33. Do, 2011, Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood–brain barrier, Mol. Cell. Biochem., 357, 397, 10.1007/s11010-011-0910-6 · DOI · Paper page
  34. Saint-Pol, 2013, Oxysterols decrease apical-to-basolateral transport of Ass peptides via an ABCB1-mediated process in an in vitro blood–brain barrier model constituted of bovine brain capillary endothelial cells, Brain Res., 1517, 1, 10.1016/j.brainres.2013.04.008 · DOI · Paper page
  35. Saint-Pol, 2012, Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-beta peptide accumulation, J. Alzheimers Dis., 30, 489, 10.3233/JAD-2012-112090 · DOI · Paper page
  36. Panzenboeck, 2006, Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells, Int. J. Biochem. Cell Biol., 38, 1314, 10.1016/j.biocel.2006.01.013 · DOI
  37. Schweinzer, 2011, Processing of endogenous AbetaPP in blood–brain barrier endothelial cells is modulated by liver-X receptor agonists and altered cellular cholesterol homeostasis, J. Alzheimers Dis., 27, 341, 10.3233/JAD-2011-110854 · DOI
  38. Meaney, 2002, On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function, J. Lipid Res., 43, 2130, 10.1194/jlr.M200293-JLR200 · DOI
  39. Ohtsuki, 2007, Brain-to-blood elimination of 24S-hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood–brain barrier, J. Neurochem., 103, 1430, 10.1111/j.1471-4159.2007.04901.x · DOI
  40. Leoni, 2013, 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases, Biochimie, 95, 595, 10.1016/j.biochi.2012.09.025 · DOI
  41. Jeitner, 2011, Oxysterol derivatives of cholesterol in neurodegenerative disorders, Curr. Med. Chem., 18, 1515, 10.2174/092986711795328445 · DOI
  42. Lynch, 2006, Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures, J. Neurosci. Res., 83, 1262, 10.1002/jnr.20809 · DOI
  43. Candela, 2010, Apical-to-basolateral transport of amyloid-beta peptides through blood–brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein, J. Alzheimers Dis., 22, 849, 10.3233/JAD-2010-100462 · DOI · Paper page
  44. Pahnke, 2008, Clinico-pathologic function of cerebral ABC transporters – implications for the pathogenesis of Alzheimer’s disease, Curr. Alzheimer Res., 5, 396, 10.2174/156720508785132262 · DOI
  45. Krohn, 2011, Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice, J. Clin. Invest., 121, 3924, 10.1172/JCI57867 · DOI · Paper page
  46. ElAli, 2012, Liver X receptor activation enhances blood–brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells, Brain Pathol., 22, 175, 10.1111/j.1750-3639.2011.00517.x · DOI · Paper page
  47. van Assema, 2012, Blood–brain barrier P-glycoprotein function in Alzheimer’s disease, Brain, 135, 181, 10.1093/brain/awr298 · DOI · Paper page
  48. Vogelgesang, 2004, The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer’s disease, Curr. Alzheimer Res., 1, 121, 10.2174/1567205043332225 · DOI
  49. Qosa, 2012, Enhanced brain amyloid-beta clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer’s disease, J. Alzheimers Dis., 31, 151, 10.3233/JAD-2012-120319 · DOI
  50. Hartz, 2010, Restoring blood–brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer’s disease, Mol. Pharmacol., 77, 715, 10.1124/mol.109.061754 · DOI
  51. Chan, 2013, Role of nuclear receptors in the regulation of drug transporters in the brain, Trends Pharmacol. Sci., 34, 361, 10.1016/j.tips.2013.05.004 · DOI
  52. Hudry, 2010, Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer’s disease, Mol. Ther., 18, 44, 10.1038/mt.2009.175 · DOI
  53. Akanuma, 2008, ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1–40) at the blood–brain barrier, Neurochem. Int., 52, 956, 10.1016/j.neuint.2007.12.002 · DOI · Paper page
  54. Ehehalt, 2003, Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts, J. Cell Biol., 160, 113, 10.1083/jcb.200207113 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Gosselet, F., Saint-Pol, J., & Fenart, L.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2014-04
Volume
446
Issue
3
Pages
687-691
ISSN
0006-291X
DOI
10.1016/j.bbrc.2013.11.059
Cited by
53
References
7
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • French Ministry for Higher Education and Research, the “Coeur et Artères” Research Foundation (06T6)
  • Ligue Européenne Contre la Maladie d’Alzheimer (09752)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review